Your browser doesn't support javascript.
loading
Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
Rokoff, Lisa B; Wallenborn, Jordyn T; Harris, Maria H; Rifas-Shiman, Sheryl L; Criswell, Rachel; Romano, Megan E; Young, Jessica G; Calafat, Antonia M; Oken, Emily; Sagiv, Sharon K; Fleisch, Abby F.
Affiliation
  • Rokoff LB; Center for Interdisciplinary Population & Health Research, MaineHealth Institute for Research, Portland, ME, USA. Electronic address: Lisa.Rokoff@mainehealth.org.
  • Wallenborn JT; Center of Excellence in Maternal, Child, and Adolescent Health, School of Public Health, University of California at Berkeley, Berkeley, CA, USA; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.
  • Harris MH; Center for Environmental Research and Children's Health, School of Public Health, University of California at Berkeley, Berkeley, CA, USA.
  • Rifas-Shiman SL; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Criswell R; Skowhegan Family Medicine, Redington-Fairview General Hospital, Skowhegan, ME, USA.
  • Romano ME; Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
  • Young JG; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Calafat AM; National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Oken E; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Sagiv SK; Center for Environmental Research and Children's Health, School of Public Health, University of California at Berkeley, Berkeley, CA, USA.
  • Fleisch AF; Center for Interdisciplinary Population & Health Research, MaineHealth Institute for Research, Portland, ME, USA; Pediatric Endocrinology and Diabetes, Maine Medical Center, Portland, ME, USA.
Sci Total Environ ; 891: 164724, 2023 Sep 15.
Article in En | MEDLINE | ID: mdl-37290653
ABSTRACT

BACKGROUND:

Per- and polyfluoroalkyl substances (PFAS) may disrupt mammary gland development and function; thereby inhibiting milk supply and breastfeeding duration. However, conclusions on the potential effects of PFAS and breastfeeding duration are limited by prior epidemiologic studies that inconsistently adjusted for past cumulative breastfeeding duration and by a lack of examination of the joint effects of PFAS mixtures.

METHODS:

In Project Viva, a longitudinal cohort that enrolled pregnant participants from 1999 to 2002 in the greater Boston, MA area, we studied 1079 women who ever attempted to lactate. We investigated associations of plasma concentrations of select PFAS in early pregnancy (mean 10.1 weeks gestation) with breastfeeding termination by 9 months, after which women typically cite self-weaning as the reason for terminating breastfeeding. We used Cox regression for single-PFAS models and quantile g-computation for mixture models, adjusting for sociodemographics, prior breastfeeding duration, and weeks of gestation at the time of blood draw.

RESULTS:

We detected 6 PFAS [perfluorooctane sulfonate; perfluorooctanoate (PFOA); perfluorohexane sulfonate; perfluorononanoate; 2-(N-ethyl-perfluorooctane sulfonamido) acetate (EtFOSAA); 2-(N-methyl-perfluorooctane sulfonamide) acetate (MeFOSAA)] in >98 % of samples. Sixty percent of lactating women terminated breastfeeding by 9 months postpartum. Women with higher plasma concentrations of PFOA, EtFOSAA, and MeFOSAA had a greater hazard of terminating breastfeeding in the first 9 months postpartum [HR (95 % CI) per doubling concentration 1.20 (1.04, 1.38) for PFOA; 1.10 (1.01, 1.20) for EtFOSAA; 1.18 (1.08, 1.30) for MeFOSAA]. In the quantile g-computation model, simultaneously increasing all PFAS in the mixture by one quartile was associated with 1.17 (95 % CI 1.05, 1.31) greater hazard of terminating breastfeeding in the first 9 months.

CONCLUSION:

Our findings suggest that exposure to PFAS may be associated with reduced breastfeeding duration and draw further attention to environmental chemicals that may dysregulate human lactation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alkanesulfonic Acids / Environmental Pollutants / Fluorocarbons Type of study: Prognostic_studies Limits: Female / Humans / Pregnancy Language: En Journal: Sci Total Environ Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alkanesulfonic Acids / Environmental Pollutants / Fluorocarbons Type of study: Prognostic_studies Limits: Female / Humans / Pregnancy Language: En Journal: Sci Total Environ Year: 2023 Document type: Article